Indications for therapy with progestational agents.
D001941:Breast Diseases / Q000188:drug therapy*; D003276:Contraceptives, Oral / Q000494:pharmacology; D004394:Dydrogesterone / Q000627:therapeutic use; D004714:Endometrial Hyperplasia / Q000188:drug therapy*; D004715:Endometriosis / Q000188:drug therapy*; D005003:Ethisterone / Q000627:therapeutic use; D005040:Ethynodiol Diacetate / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000188:drug therapy*; D001523:Mental Disorders / Q000188:drug therapy*; D008881:Migraine Disorders / Q000188:drug therapy*; D009640:Norethindrone / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*
D003276:Contraceptives, Oral; D011372:Progestins; D011374:Progesterone; D005040:Ethynodiol Diacetate; D004394:Dydrogesterone; D008525:Medroxyprogesterone; D005003:Ethisterone; D009640:Norethindrone